At the end of this course, students will be able to design a clinical development for a lead compound.
Students will be asked to design a clinical development (Phase I, Phase II, and Phase III study) for a lead compound, which has just completed pre-clinical investigations.
Clinical trials are presented and discussed.
A case study is assigned to each group of 2 or 3 students.
Students will be divided in small groups (2-3) to work on a case study. This latter will be presented and discussed with a jury composed of professors in the field.
| Training | Study programme | Block | Credits | Mandatory |
|---|---|---|---|---|
| Master 120 en sciences biomédicales à finalité spécialisée en recherche clinique | Standard | 0 | 4 | |
| Master 120 en sciences biomédicales à finalité spécialisée en recherche clinique | Standard | 2 | 4 |